156 related articles for article (PubMed ID: 5663560)
1. The urinary calcium-magnesium ratio in calcigerous stone formers.
King JS; O'Connor FJ; Smith MJ; Crouse L
Invest Urol; 1968 Jul; 6(1):60-5. PubMed ID: 5663560
[No Abstract] [Full Text] [Related]
2. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
[TBL] [Abstract][Full Text] [Related]
3. Circadian variations of blood and urinary constituents in renal stone formers.
Singh RK; Bansal A; Bansal SK; Rai SP
Prog Clin Biol Res; 1990; 341B():551-7. PubMed ID: 2217342
[No Abstract] [Full Text] [Related]
4. Urine oxalate and calcium in idiopathic renal stone formers.
Wallace MR; Mason K; Gray J
N Z Med J; 1981 Aug; 94(689):87-9. PubMed ID: 6944647
[No Abstract] [Full Text] [Related]
5. The urinary excretion of oxalic acid and magnesium in oxalate urolithiasis.
Takasaki E; Shimano E
Invest Urol; 1967 Nov; 5(3):303-12. PubMed ID: 6073639
[No Abstract] [Full Text] [Related]
6. Study of inhibitor and nucleator activities in calcium stone formers.
Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
[TBL] [Abstract][Full Text] [Related]
7. Activity products in stone-forming and non-stone-forming urine.
Robertson WG; Peacock M; Nordin BE
Clin Sci; 1968 Jun; 34(3):579-94. PubMed ID: 5666884
[No Abstract] [Full Text] [Related]
8. Diurnal variations in calcium phosphate and calcium oxalate activity products in normal and stone-forming urines.
Hodgkinson A; Marshall RW; Cochran M
Isr J Med Sci; 1971 Nov; 7(11):1230-4. PubMed ID: 5159604
[No Abstract] [Full Text] [Related]
9. [Clinical and chemical factors in kidney calculus formation in childhood. An analysis of 40 patients].
Böhles H; Brandl U; Schott G; Stehr K
Monatsschr Kinderheilkd; 1984 Mar; 132(3):158-62. PubMed ID: 6727888
[TBL] [Abstract][Full Text] [Related]
10. Magnesium metabolism in renal stone disease.
Johansson G; Backman U; Danielson BG; Ljunghall S; Wikström B
Invest Urol; 1980 Sep; 18(2):93-6. PubMed ID: 7410037
[TBL] [Abstract][Full Text] [Related]
11. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.
Robertson WG; Peacock M; Nordin BE
Clin Sci; 1971 May; 40(5):365-74. PubMed ID: 5556093
[No Abstract] [Full Text] [Related]
12. [Diagnosis of relative hypomagnesurea in calcium lithiasis: reference values for a new parameter].
Labeeuw M; Pozet N; Gerbaulet C; Zech P; Traeger J
Nephrologie; 1984; 5(3):101-5. PubMed ID: 6493428
[TBL] [Abstract][Full Text] [Related]
13. Magnesium metabolism in renal stone formers. Effects of therapy with magnesium hydroxide.
Johansson G; Backman U; Danielson BG; Fellström B; Ljunghall S; Wikström B
Scand J Urol Nephrol Suppl; 1980; 53():125-34. PubMed ID: 6937988
[No Abstract] [Full Text] [Related]
14. [Urinary excretion of calcium, magnesium and uric acid in kidney stone patients, their asymptomatic relatives and healthy subjects].
González-Calvin JL; Montero García M; García Valdecasas J; Luna J; Raya Muñoz J; Peña Angulo JF; Peña Yáñez A
Rev Clin Esp; 1981 Feb; 160(4):247-50. PubMed ID: 7268117
[No Abstract] [Full Text] [Related]
15. [Urine analyses for workup of kidney stone disease--interpretation and therapeutic consequences].
Pasch A
Ther Umsch; 2006 Sep; 63(9):569-74. PubMed ID: 17048170
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi.
Thomas WC
Trans Am Clin Climatol Assoc; 1972; 83():113-24. PubMed ID: 5040108
[No Abstract] [Full Text] [Related]
17. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
18. Direct titrimetric determination of uric acid separately and in urine of patients containing stone.
Shyam H; Saxena OC
Ital J Biochem; 1973; 22(2):65-73. PubMed ID: 4771416
[No Abstract] [Full Text] [Related]
19. Alterations in some risk factors and urinary enzymes in urolithiatic rats treated with sodium pentosan polysulphate.
Subha K; Varalakshmi P
Biochem Mol Biol Int; 1993 Feb; 29(2):271-80. PubMed ID: 7684293
[TBL] [Abstract][Full Text] [Related]
20. [Experimental investigation on the possibility of influencing the solubility of mineral renal stones].
Knappwost A; Matouschek E
Urol Int; 1973; 28(1):9-20. PubMed ID: 4693759
[No Abstract] [Full Text] [Related]
[Next] [New Search]
